Leap Therapeutics Inc (NASDAQ:LPTX)

1.97
Delayed Data
As of Sep 18
 +0.06 / +3.14%
Today’s Change
0.57
Today|||52-Week Range
3.18
+75.89%
Year-to-Date
Leap Therapeutics files for $150M mixed shelf
Sep 14 / Seeking Alpha - Paid Partner Content
 

Today’s Trading

Previous close1.91
Today’s open1.92
Day’s range1.92 - 2.04
Volume31,893
Average volume (3 months)749,741
Market cap$111.9M
Data as of 3:59pm ET, 09/18/2020

Growth & Valuation

Earnings growth (last year)+9.96%
Earnings growth (this year)+47.48%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CSBRChampions Oncology I...+0.48+5.57%
PLXProtalix Biotherapeu...+0.16+4.42%
VCNXVaccinex Inc-0.25-4.22%
SRRASierra Oncology Inc-0.52-4.35%
Data as of 3:58pm ET, 09/18/2020

Financials

Next reporting dateNovember 11, 2020
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$0.00
Annual profit (last year)-$32.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts